Del Rio M - Search Results

1

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors.

García M, Bonafont J, Martínez-Palacios J, Xu R, Turchiano G, Svensson S, Thrasher AJ, Larcher F, Del Rio M, Hernández-Alcoceba R, Garín MI, Mencía Á, Murillas R. García M, et al. Among authors: del rio m. Mol Ther Methods Clin Dev. 2022 Sep 16;27:96-108. doi: 10.1016/j.omtm.2022.09.005. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36212909 Free PMC article.

2

A preclinical model for the analysis of genetically modified human skin in vivo.

Del Rio M, Larcher F, Serrano F, Meana A, Muñoz M, Garcia M, Muñoz E, Martin C, Bernad A, Jorcano JL. Del Rio M, et al. Hum Gene Ther. 2002 May 20;13(8):959-68. doi: 10.1089/10430340252939069. Hum Gene Ther. 2002. PMID: 12031128

3

Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta.

Redondo S, Santos-Gallego CG, Ganado P, García M, Rico L, Del Rio M, Tejerina T. Redondo S, et al. Among authors: del rio m. Circulation. 2003 Feb 4;107(4):626-9. doi: 10.1161/01.cir.0000045664.75269.a5. Circulation. 2003. PMID: 12566377

4

A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.

Serrano F, Del Rio M, Larcher F, Garcia M, Muñoz E, Escamez MJ, Muñoz M, Meana A, Bernad A, Jorcano JL. Serrano F, et al. Among authors: del rio m. Hum Gene Ther. 2003 Nov 1;14(16):1579-85. doi: 10.1089/104303403322495089. Hum Gene Ther. 2003. PMID: 14577919

5

Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin.

Llames SG, Del Rio M, Larcher F, García E, García M, Escamez MJ, Jorcano JL, Holguín P, Meana A. Llames SG, et al. Among authors: del rio m. Transplantation. 2004 Feb 15;77(3):350-5. doi: 10.1097/01.TP.0000112381.80964.85. Transplantation. 2004. PMID: 14966407

6

Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.

Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M. Garcia M, et al. Among authors: del rio m. Cancer Res. 2004 Aug 15;64(16):5632-42. doi: 10.1158/0008-5472.CAN-04-0230. Cancer Res. 2004. PMID: 15313901

7

Current approaches and perspectives in human keratinocyte-based gene therapies.

Del Rio M, Gache Y, Jorcano JL, Meneguzzi G, Larcher F. Del Rio M, et al. Gene Ther. 2004 Oct;11 Suppl 1:S57-63. doi: 10.1038/sj.gt.3302370. Gene Ther. 2004. PMID: 15454958 Review.

8

A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.

Carretero M, Del Río M, García M, Escámez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F. Carretero M, et al. Among authors: del rio m. FASEB J. 2004 Dec;18(15):1931-3. doi: 10.1096/fj.04-1515fje. Epub 2004 Sep 29. FASEB J. 2004. PMID: 15456737

9

Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.

Gache Y, Baldeschi C, Del Rio M, Gagnoux-Palacios L, Larcher F, Lacour JP, Meneguzzi G. Gache Y, et al. Among authors: del rio m. Hum Gene Ther. 2004 Oct;15(10):921-33. doi: 10.1089/hum.2004.15.921. Hum Gene Ther. 2004. PMID: 15585108

10

An in vivo model of wound healing in genetically modified skin-humanized mice.

Escámez MJ, García M, Larcher F, Meana A, Muñoz E, Jorcano JL, Del Río M. Escámez MJ, et al. Among authors: del rio m. J Invest Dermatol. 2004 Dec;123(6):1182-91. doi: 10.1111/j.0022-202X.2004.23473.x. J Invest Dermatol. 2004. PMID: 15610532 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page